source
- Supreme Court sides with Hikma in 'skinny label' caseThe Supreme Court unanimously sided with Hikma Pharmaceuticals and its “skinny label” version of a prescription-strength fish oil pill in a case that was closely watched by the generics industry. T…Endpoints · 1mo ago↗ source
- Novo Holdings backs European fund; Alnylam sends second obesity drug into clinicPlus news about IMU Biosciences, Autobahn and Jade Biosciences. 💸 Novo Holdings invests in Europe-focused fund: The investment manager of the Novo Nordisk Foundation's fortunes is backing the Scal…Endpoints · 1mo ago↗ source
- Alnylam, Inceptive ink AI deal potentially worth $2BThe RNA-focused drugmaker says Inceptive's tools will help prioritize the best development options as well as speed up the research process.